BRCA1 and ovarian cancer: However, a considerable proportion of cancer cells from BRCA1-deficient breast or ovarian cancer patients bear no p53 mutations (Ramus et al., 1999; Greenblatt et al., 2001; Manie et al., 2009; Jonsson et al., 2019).